Full Text View
Tabular View
No Study Results Posted
Related Studies
Conversion From Standard Phosphate Binder Therapy to Fosrenol® (Lanthanum Carbonate) in Chronic Kidney Disease Stage 5
This study has been terminated.
( This study was stopped by the sponsor based on a non-safety related corporate decision )
Study NCT00452478   Information provided by Shire Pharmaceutical Development
First Received: March 23, 2007   Last Updated: December 18, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Kidney Diseases
Additional conditions recognized in this trial
Kidney Failure, Chronic
Renal Insufficiency, Chronic
More general conditions related to this trial
Kidney Failure
Renal Insufficiency
Urologic Diseases
Interventions listed in this trial
Lanthanum carbonate
Sponsors listed in this trial
Shire Pharmaceutical Development


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services